Approval · Notice of Compliance 14391 · 2013
TIMENTIN: Notice of Compliance 14391
Issued April 19, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14391
- Date
- April 19, 2013
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To register facility changes made to the Parenterals Business Unit for the manufacturer of sterile drug product
- Therapeutic class
- Antibiotic and beta lactamase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TIMENTIN | Not yet assigned | — |
Medicinal ingredients
- CLAVULANIC ACID POTASSIUM SALT 100 MG per VIAL
- TICARCILLIN DISODIUM 3 G per VIAL
- TICARCILLIN DISODIUM 30 G per VIAL
- CLAVULANIC ACID 1 G per VIAL